Q9CS84 · NRX1A_MOUSE
- ProteinNeurexin-1
- GeneNrxn1
- StatusUniProtKB reviewed (Swiss-Prot)
- Organism
- Amino acids1514 (go to sequence)
- Protein existenceEvidence at protein level
- Annotation score5/5
Function
function
Features
Showing features for binding site.
Type | ID | Position(s) | Description | |||
---|---|---|---|---|---|---|
Binding site | 329 | Ca2+ 1 (UniProtKB | ChEBI) | ||||
Sequence: D | ||||||
Binding site | 346 | Ca2+ 1 (UniProtKB | ChEBI) | ||||
Sequence: L | ||||||
Binding site | 414 | Ca2+ 1 (UniProtKB | ChEBI) | ||||
Sequence: M | ||||||
Binding site | 772 | Ca2+ 2 (UniProtKB | ChEBI) | ||||
Sequence: D | ||||||
Binding site | 789 | Ca2+ 2 (UniProtKB | ChEBI) | ||||
Sequence: L | ||||||
Binding site | 848 | Ca2+ 2 (UniProtKB | ChEBI) | ||||
Sequence: R | ||||||
Binding site | 1183 | Ca2+ 3 (UniProtKB | ChEBI) | ||||
Sequence: D | ||||||
Binding site | 1200 | Ca2+ 3 (UniProtKB | ChEBI) | ||||
Sequence: V | ||||||
Binding site | 1282 | Ca2+ 3 (UniProtKB | ChEBI) | ||||
Sequence: I | ||||||
Binding site | 1284 | Ca2+ 3 (UniProtKB | ChEBI) | ||||
Sequence: N |
GO annotations
all annotations | all molecular function | virus receptor activity | dna binding | rna binding | cytoskeletal motor activity | catalytic activity | gtpase activity | structural molecule activity | transporter activity | cytoskeletal protein binding | lipid binding | cyclase activity | antioxidant activity | oxidoreductase activity | transferase activity | hydrolase activity | lyase activity | isomerase activity | ligase activity | protein tag activity | cargo receptor activity | histone binding | protein folding chaperone | translation regulator activity | nutrient reservoir activity | receptor ligand activity | molecular transducer activity | molecular adaptor activity | toxin activity | cell adhesion mediator activity | molecular function regulator activity | virus coreceptor activity | catalytic activity, acting on a protein | catalytic activity, acting on dna | catalytic activity, acting on rna | molecular carrier activity | transcription regulator activity | general transcription initiation factor activity | molecular sensor activity | molecular sequestering activity | atp-dependent activity | other molecular function | all biological process | mitotic cell cycle | cytokinesis | cytoplasmic translation | immune system process | muscle system process | circulatory system process | renal system process | respiratory system process | carbohydrate metabolic process | generation of precursor metabolites and energy | dna replication | dna repair | dna recombination | chromatin organization | dna-templated transcription | regulation of dna-templated transcription | trna metabolic process | protein folding | protein glycosylation | amino acid metabolic process | modified amino acid metabolic process | lipid metabolic process | vitamin metabolic process | sulfur compound metabolic process | intracellular protein transport | nucleocytoplasmic transport | autophagy | inflammatory response | mitochondrion organization | cytoskeleton organization | microtubule-based movement | peroxisome organization | lysosome organization | chromosome segregation | cell adhesion | establishment or maintenance of cell polarity | programmed cell death | photosynthesis | mrna metabolic process | snrna metabolic process | vesicle-mediated transport | reproductive process | digestive system process | signaling | cell differentiation | protein catabolic process | extracellular matrix organization | regulatory ncrna-mediated gene silencing | telomere organization | cell junction organization | wound healing | ribosome biogenesis | cilium organization | anatomical structure development | cell motility | nervous system process | endocrine process | protein maturation | transmembrane transport | nucleobase-containing small molecule metabolic process | hepaticobiliary system process | membrane organization | protein-containing complex assembly | cell wall organization or biogenesis | nitrogen cycle metabolic process | protein localization to plasma membrane | defense response to other organism | detoxification | meiotic nuclear division | mitotic nuclear division | mitochondrial gene expression | carbohydrate derivative metabolic process | other biological process | all cellular component | nuclear chromosome | extracellular region | extracellular space | cell wall | nucleus | nuclear envelope | nucleoplasm | chromosome | nucleolus | mitochondrion | lysosome | endosome | vacuole | peroxisome | endoplasmic reticulum | golgi apparatus | lipid droplet | microtubule organizing center | cytosol | ribosome | cytoskeleton | plasma membrane | cilium | plastid | thylakoid | external encapsulating structure | extracellular matrix | cytoplasmic vesicle | organelle | other cellular component | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Keywords
- Biological process
- Ligand
Enzyme and pathway databases
Names & Taxonomy
Protein names
- Recommended nameNeurexin-1
- Alternative names
Gene names
Organism names
- Organism
- Strains
- Taxonomic lineageEukaryota > Metazoa > Chordata > Craniata > Vertebrata > Euteleostomi > Mammalia > Eutheria > Euarchontoglires > Glires > Rodentia > Myomorpha > Muroidea > Muridae > Murinae > Mus > Mus
Accessions
- Primary accessionQ9CS84
- Secondary accessions
Proteomes
Organism-specific databases
Subcellular Location
Features
Showing features for topological domain, transmembrane.
Type | ID | Position(s) | Description | |||
---|---|---|---|---|---|---|
Topological domain | 31-1438 | Extracellular | ||||
Sequence: LEFPGAEGQWTRFPKWNACCESEMSFQLKTRSARGLVLYFDDEGFCDFLELILTRGGRLQLSFSIFCAEPATLLADTPVNDGAWHSVRIRRQFRNTTLYIDRAEAKWVEVKSKRRDMTVFSGLFVGGLPPELRAAALKLTLASVREREPFKGWIRDVRVNSSQALPVDGGEVKLDDEPPNSGGGSPCEAGEEGEGGVCLNGGVCSVVDDQAVCDCSRTGFRGKDCSQEDNNVEGLAHLMMGDQGKSKGKEEYIATFKGSEYFCYDLSQNPIQSSSDEITLSFKTLQRNGLMLHTGKSADYVNLALKNGAVSLVINLGSGAFEALVEPVNGKFNDNAWHDVKVTRNLRQHSGIGHAMVNKLHCSVTISVDGILTTTGYTQEDYTMLGSDDFFYVGGSPSTADLPGSPVSNNFMGCLKEVVYKNNDVRLELSRLAKQGDPKMKIHGVVAFKCENVATLDPITFETPESFISLPKWNAKKTGSISFDFRTTEPNGLILFSHGKPRHQKDAKHPQMIKVDFFAIEMLDGHLYLLLDMGSGTIKIKALQKKVNDGEWYHVDFQRDGRSGTISVNTLRTPYTAPGESEILDLDDELYLGGLPENKAGLVFPTEVWTALLNYGYVGCIRDLFIDGQSKDIRQMAEIQSTAGVKPSCSKETAKPCLSNPCKNNGMCRDGWNRYVCDCSGTGYLGRSCEREATVLSYDGSMFMKIQLPVVMHTEAEDVSLRFRSQRAYGILMATTSRDSADTLRLELDAGRVKLTVNLDCIRINCNSSKGPETLFAGYNLNDNEWHTVRVVRRGKSLKLTVDDQQAMTGQMAGDHTRLEFHNIETGIITERRYLSSVPSNFIGHLQSLTFNGMAYIDLCKNGDIDYCELNARFGFRNIIADPVTFKTKSSYVALATLQAYTSMHLFFQFKTTSLDGLILYNSGDGNDFIVVELVKGYLHYVFDLGNGANLIKGSSNKPLNDNQWHNVMISRDTSNLHTVKIDTKITTQITAGARNLDLKSDLYIGGVAKETYKSLPKLVHAKEGFQGCLASVDLNGRLPDLISDALFCNGQIERGCEGPSTTCQEDSCSNQGVCLQQWDGFSCDCSMTSFSGPLCNDPGTTYIFSKGGGQITYKWPPNDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIEESNAIINDGKYHVVRFTRSGGNATLQVDSWPVIERYPAGNNDNERLAIARQRIPYRLGRVVDEWLLDKGRQLTIFNSQATIIIGGKEQGQPFQGQLSGLYYNGLKVLNMAAENDANIAIVGNVRLVGEVPSSMTTESTATAMQSEMSTSIMETTTTLATSTARRGKPPTKEPISQTTDDILVASAECPSDDEDIDPCEPSSGGLANPTRVGGREPYPGSAEVIRESSSTT | ||||||
Transmembrane | 1439-1459 | Helical | ||||
Sequence: GMVVGIVAAAALCILILLYAM | ||||||
Topological domain | 1460-1514 | Cytoplasmic | ||||
Sequence: YKYRNRDEGSYHVDESRNYISNSAQSNGAVVKEKQPSSAKSANKNKKNKDKEYYV |
Keywords
- Cellular component
Phenotypes & Variants
Disruption phenotype
Features
Showing features for mutagenesis.
Type | ID | Position(s) | Description | |||
---|---|---|---|---|---|---|
Mutagenesis | 1392 | Abolishes heparan sulfate attachment. | ||||
Sequence: S → A |
Variants
We now provide the "Disease & Variants" viewer in its own tab.
The viewer provides 57 variants from UniProt as well as other sources including ClinVar and dbSNP.
PTM/Processing
Features
Showing features for signal, chain, glycosylation, disulfide bond.
Type | ID | Position(s) | Description | |||
---|---|---|---|---|---|---|
Signal | 1-30 | |||||
Sequence: MGTALVQRGGCCLLCLSLLLLGCWAELGSG | ||||||
Chain | PRO_0000043164 | 31-1514 | Neurexin-1 | |||
Sequence: LEFPGAEGQWTRFPKWNACCESEMSFQLKTRSARGLVLYFDDEGFCDFLELILTRGGRLQLSFSIFCAEPATLLADTPVNDGAWHSVRIRRQFRNTTLYIDRAEAKWVEVKSKRRDMTVFSGLFVGGLPPELRAAALKLTLASVREREPFKGWIRDVRVNSSQALPVDGGEVKLDDEPPNSGGGSPCEAGEEGEGGVCLNGGVCSVVDDQAVCDCSRTGFRGKDCSQEDNNVEGLAHLMMGDQGKSKGKEEYIATFKGSEYFCYDLSQNPIQSSSDEITLSFKTLQRNGLMLHTGKSADYVNLALKNGAVSLVINLGSGAFEALVEPVNGKFNDNAWHDVKVTRNLRQHSGIGHAMVNKLHCSVTISVDGILTTTGYTQEDYTMLGSDDFFYVGGSPSTADLPGSPVSNNFMGCLKEVVYKNNDVRLELSRLAKQGDPKMKIHGVVAFKCENVATLDPITFETPESFISLPKWNAKKTGSISFDFRTTEPNGLILFSHGKPRHQKDAKHPQMIKVDFFAIEMLDGHLYLLLDMGSGTIKIKALQKKVNDGEWYHVDFQRDGRSGTISVNTLRTPYTAPGESEILDLDDELYLGGLPENKAGLVFPTEVWTALLNYGYVGCIRDLFIDGQSKDIRQMAEIQSTAGVKPSCSKETAKPCLSNPCKNNGMCRDGWNRYVCDCSGTGYLGRSCEREATVLSYDGSMFMKIQLPVVMHTEAEDVSLRFRSQRAYGILMATTSRDSADTLRLELDAGRVKLTVNLDCIRINCNSSKGPETLFAGYNLNDNEWHTVRVVRRGKSLKLTVDDQQAMTGQMAGDHTRLEFHNIETGIITERRYLSSVPSNFIGHLQSLTFNGMAYIDLCKNGDIDYCELNARFGFRNIIADPVTFKTKSSYVALATLQAYTSMHLFFQFKTTSLDGLILYNSGDGNDFIVVELVKGYLHYVFDLGNGANLIKGSSNKPLNDNQWHNVMISRDTSNLHTVKIDTKITTQITAGARNLDLKSDLYIGGVAKETYKSLPKLVHAKEGFQGCLASVDLNGRLPDLISDALFCNGQIERGCEGPSTTCQEDSCSNQGVCLQQWDGFSCDCSMTSFSGPLCNDPGTTYIFSKGGGQITYKWPPNDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIEESNAIINDGKYHVVRFTRSGGNATLQVDSWPVIERYPAGNNDNERLAIARQRIPYRLGRVVDEWLLDKGRQLTIFNSQATIIIGGKEQGQPFQGQLSGLYYNGLKVLNMAAENDANIAIVGNVRLVGEVPSSMTTESTATAMQSEMSTSIMETTTTLATSTARRGKPPTKEPISQTTDDILVASAECPSDDEDIDPCEPSSGGLANPTRVGGREPYPGSAEVIRESSSTTGMVVGIVAAAALCILILLYAMYKYRNRDEGSYHVDESRNYISNSAQSNGAVVKEKQPSSAKSANKNKKNKDKEYYV | ||||||
Glycosylation | 125 | N-linked (GlcNAc...) asparagine | ||||
Sequence: N | ||||||
Glycosylation | 190 | N-linked (GlcNAc...) asparagine | ||||
Sequence: N | ||||||
Disulfide bond | 228↔243 | |||||
Sequence: CLNGGVCSVVDDQAVC | ||||||
Disulfide bond | 245↔255 | |||||
Sequence: CSRTGFRGKDC | ||||||
Disulfide bond | 444↔480 | |||||
Sequence: CLKEVVYKNNDVRLELSRLAKQGDPKMKIHGVVAFKC | ||||||
Disulfide bond | 650↔679 | |||||
Sequence: CIRDLFIDGQSKDIRQMAEIQSTAGVKPSC | ||||||
Disulfide bond | 687↔698 | |||||
Sequence: CLSNPCKNNGMC | ||||||
Disulfide bond | 692↔707 | |||||
Sequence: CKNNGMCRDGWNRYVC | ||||||
Disulfide bond | 709↔719 | |||||
Sequence: CSGTGYLGRSC | ||||||
Glycosylation | 797 | N-linked (GlcNAc...) asparagine | ||||
Sequence: N | ||||||
Disulfide bond | 890↔898 | |||||
Sequence: CKNGDIDYC | ||||||
Disulfide bond | 1059↔1087 | |||||
Sequence: CLASVDLNGRLPDLISDALFCNGQIERGC | ||||||
Disulfide bond | 1094↔1105 | |||||
Sequence: CQEDSCSNQGVC | ||||||
Disulfide bond | 1099↔1114 | |||||
Sequence: CSNQGVCLQQWDGFSC | ||||||
Disulfide bond | 1116↔1126 | |||||
Sequence: CSMTSFSGPLC | ||||||
Glycosylation | 1230 | N-linked (GlcNAc...) asparagine | ||||
Sequence: N | ||||||
Glycosylation | 1392 | O-linked (Xyl...) (heparan sulfate) serine | ||||
Sequence: S |
Post-translational modification
Keywords
- PTM
Proteomic databases
PTM databases
Expression
Gene expression databases
Interaction
Subunit
Also interacts (via laminin G-like domain 2 and/or laminin G-like domain 6) with NLGN2, NLGN3 and NLGN4L; interactions with NLGN1, NLGN2, NLGN3 and NLGN4L are calcium-dependent (PubMed:18434543, PubMed:20624592).
Interacts (via cytoplasmic C-terminal region) with CASK (via the PDZ, SH3 and guanylate kinase-like domains) (PubMed:25385611).
Interacts (via cytoplasmic C-terminus) with CASKIN1 and APBA1 (By similarity).
Interacts (via laminin G-like domain 2) with NXPH1 and NXPH3 (By similarity).
Alpha-type isoforms (neurexin-1-alpha) interact (via laminin G-like domain 2 and/or laminin G-like domain 6) with DAG1 (via alpha-dystroglycan chain) (By similarity).
Interacts with LRRTM1, LRRTM2, LRRTM3 and LRRTM4 (By similarity).
Interacts with SYT13 and SYTL1 (PubMed:11171101, PubMed:11243866).
Interacts with CBLN1, CBLN2 and, less avidly, with CBLN4 (PubMed:21410790).
Interacts with CLSTN3 (PubMed:24094106, PubMed:24613359, PubMed:32434929).
Binary interactions
Type | Entry 1 | Entry 2 | Number of experiments | Intact | |
---|---|---|---|---|---|
XENO | Q9CS84 | PTPRT O14522 | 2 | EBI-399696, EBI-728180 |
Protein-protein interaction databases
Miscellaneous
Structure
Family & Domains
Features
Showing features for domain, region, compositional bias.
Type | ID | Position(s) | Description | |||
---|---|---|---|---|---|---|
Domain | 31-217 | Laminin G-like 1 | ||||
Sequence: LEFPGAEGQWTRFPKWNACCESEMSFQLKTRSARGLVLYFDDEGFCDFLELILTRGGRLQLSFSIFCAEPATLLADTPVNDGAWHSVRIRRQFRNTTLYIDRAEAKWVEVKSKRRDMTVFSGLFVGGLPPELRAAALKLTLASVREREPFKGWIRDVRVNSSQALPVDGGEVKLDDEPPNSGGGSPC | ||||||
Region | 197-221 | Disordered | ||||
Sequence: VDGGEVKLDDEPPNSGGGSPCEAGE | ||||||
Domain | 219-256 | EGF-like 1 | ||||
Sequence: AGEEGEGGVCLNGGVCSVVDDQAVCDCSRTGFRGKDCS | ||||||
Domain | 283-480 | Laminin G-like 2 | ||||
Sequence: IATFKGSEYFCYDLSQNPIQSSSDEITLSFKTLQRNGLMLHTGKSADYVNLALKNGAVSLVINLGSGAFEALVEPVNGKFNDNAWHDVKVTRNLRQHSGIGHAMVNKLHCSVTISVDGILTTTGYTQEDYTMLGSDDFFYVGGSPSTADLPGSPVSNNFMGCLKEVVYKNNDVRLELSRLAKQGDPKMKIHGVVAFKC | ||||||
Domain | 487-679 | Laminin G-like 3 | ||||
Sequence: DPITFETPESFISLPKWNAKKTGSISFDFRTTEPNGLILFSHGKPRHQKDAKHPQMIKVDFFAIEMLDGHLYLLLDMGSGTIKIKALQKKVNDGEWYHVDFQRDGRSGTISVNTLRTPYTAPGESEILDLDDELYLGGLPENKAGLVFPTEVWTALLNYGYVGCIRDLFIDGQSKDIRQMAEIQSTAGVKPSC | ||||||
Domain | 683-720 | EGF-like 2 | ||||
Sequence: TAKPCLSNPCKNNGMCRDGWNRYVCDCSGTGYLGRSCE | ||||||
Domain | 725-898 | Laminin G-like 4 | ||||
Sequence: VLSYDGSMFMKIQLPVVMHTEAEDVSLRFRSQRAYGILMATTSRDSADTLRLELDAGRVKLTVNLDCIRINCNSSKGPETLFAGYNLNDNEWHTVRVVRRGKSLKLTVDDQQAMTGQMAGDHTRLEFHNIETGIITERRYLSSVPSNFIGHLQSLTFNGMAYIDLCKNGDIDYC | ||||||
Domain | 912-1087 | Laminin G-like 5 | ||||
Sequence: DPVTFKTKSSYVALATLQAYTSMHLFFQFKTTSLDGLILYNSGDGNDFIVVELVKGYLHYVFDLGNGANLIKGSSNKPLNDNQWHNVMISRDTSNLHTVKIDTKITTQITAGARNLDLKSDLYIGGVAKETYKSLPKLVHAKEGFQGCLASVDLNGRLPDLISDALFCNGQIERGC | ||||||
Domain | 1090-1127 | EGF-like 3 | ||||
Sequence: PSTTCQEDSCSNQGVCLQQWDGFSCDCSMTSFSGPLCN | ||||||
Domain | 1133-1331 | Laminin G-like 6 | ||||
Sequence: YIFSKGGGQITYKWPPNDRPSTRADRLAIGFSTVQKEAVLVRVDSSSGLGDYLELHIHQGKIGVKFNVGTDDIAIEESNAIINDGKYHVVRFTRSGGNATLQVDSWPVIERYPAGNNDNERLAIARQRIPYRLGRVVDEWLLDKGRQLTIFNSQATIIIGGKEQGQPFQGQLSGLYYNGLKVLNMAAENDANIAIVGNV | ||||||
Region | 1396-1427 | Disordered | ||||
Sequence: PSDDEDIDPCEPSSGGLANPTRVGGREPYPGS | ||||||
Compositional bias | 1481-1497 | Polar residues | ||||
Sequence: NSAQSNGAVVKEKQPSS | ||||||
Region | 1481-1507 | Interaction with CASK | ||||
Sequence: NSAQSNGAVVKEKQPSSAKSANKNKKN | ||||||
Region | 1481-1514 | Disordered | ||||
Sequence: NSAQSNGAVVKEKQPSSAKSANKNKKNKDKEYYV | ||||||
Compositional bias | 1498-1514 | Basic and acidic residues | ||||
Sequence: AKSANKNKKNKDKEYYV |
Sequence similarities
Keywords
- Domain
Phylogenomic databases
Family and domain databases
Sequence & Isoforms
- Sequence statusComplete
- Sequence processingThe displayed sequence is further processed into a mature form.
This entry describes 7 isoforms produced by Alternative promoter usage & Alternative splicing. A number of isoforms, alpha-type and beta-type are produced by alternative promoter usage. Beta-type isoforms differ from alpha-type isoforms in their N-terminus.
Q9CS84-1
This isoform has been chosen as the canonical sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
- Name1a
- Length1,514
- Mass (Da)166,169
- Last updated2005-12-06 v3
- Checksum412281FE441F0EFC
Q9CS84-2
- Name2a
- SynonymsAlpha-2B
- Differences from canonical
- 387-393: Missing
Q9CS84-3
- Name3a
- SynonymsAlpha-2C
- Differences from canonical
- 379-393: Missing
Q9CS84-4
- Name4a
- Differences from canonical
- 379-393: Missing
- 1410-1412: Missing
P0DI97-1
The sequence of this isoform can be found in the external entry linked below. Isoforms of the same protein are often annotated in two different entries if their sequences differ significantly.
View isoform- Name1b
Q9CS84-5
- Name5a
- Differences from canonical
- 387-393: Missing
- 1247-1276: Missing
Q9CS84-6
- Name6
- NoteProduced by alternative promoter usage and alternative splicing.
- Differences from canonical
- 1-1372: Missing
- 1373-1381: GKPPTKEPI → MDMRWHCEN
- 1410-1412: Missing
Computationally mapped potential isoform sequences
There are 10 potential isoforms mapped to this entry
Entry | Entry name | Gene name | Length | ||
---|---|---|---|---|---|
P0DI97 | NRX1B_MOUSE | Nrxn1 | 468 | ||
H3BK41 | H3BK41_MOUSE | Nrxn1 | 213 | ||
G3UWQ9 | G3UWQ9_MOUSE | Nrxn1 | 142 | ||
A0A0H2UH29 | A0A0H2UH29_MOUSE | Nrxn1 | 465 | ||
E0CZA5 | E0CZA5_MOUSE | Nrxn1 | 438 | ||
E0CY11 | E0CY11_MOUSE | Nrxn1 | 1495 | ||
A0A0G2JE65 | A0A0G2JE65_MOUSE | Nrxn1 | 169 | ||
A0A0G2JE40 | A0A0G2JE40_MOUSE | Nrxn1 | 186 | ||
A0A140LI71 | A0A140LI71_MOUSE | Nrxn1 | 75 | ||
A0A0G2JES8 | A0A0G2JES8_MOUSE | Nrxn1 | 172 |
Sequence caution
Features
Showing features for alternative sequence, compositional bias.
Type | ID | Position(s) | Description | |||
---|---|---|---|---|---|---|
Alternative sequence | VSP_058203 | 1-1372 | in isoform 6 | |||
Sequence: Missing | ||||||
Alternative sequence | VSP_003485 | 379-393 | in isoform 3a and isoform 4a | |||
Sequence: Missing | ||||||
Alternative sequence | VSP_003484 | 387-393 | in isoform 2a and isoform 5a | |||
Sequence: Missing | ||||||
Alternative sequence | VSP_043946 | 1247-1276 | in isoform 5a | |||
Sequence: Missing | ||||||
Alternative sequence | VSP_058204 | 1373-1381 | in isoform 6 | |||
Sequence: GKPPTKEPI → MDMRWHCEN | ||||||
Alternative sequence | VSP_016401 | 1410-1412 | in isoform 4a and isoform 6 | |||
Sequence: Missing | ||||||
Compositional bias | 1481-1497 | Polar residues | ||||
Sequence: NSAQSNGAVVKEKQPSS | ||||||
Compositional bias | 1498-1514 | Basic and acidic residues | ||||
Sequence: AKSANKNKKNKDKEYYV |
Keywords
- Coding sequence diversity
- Technical term
Sequence databases
Nucleotide Sequence | Protein Sequence | Molecule Type | Status | |
---|---|---|---|---|
AB093249 EMBL· GenBank· DDBJ | BAC41433.2 EMBL· GenBank· DDBJ | mRNA | Different initiation | |
AC101872 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
AC131326 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
AC151286 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
AC154325 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
AC154599 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
AC167814 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
AC170901 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
AC171209 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
CT025708 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
CT486002 EMBL· GenBank· DDBJ | - | Genomic DNA | No translation available. | |
BC047146 EMBL· GenBank· DDBJ | AAH47146.1 EMBL· GenBank· DDBJ | mRNA | Sequence problems. | |
AF387674 EMBL· GenBank· DDBJ | AAK70469.1 EMBL· GenBank· DDBJ | Genomic DNA | ||
AF387674 EMBL· GenBank· DDBJ | AAK70470.1 EMBL· GenBank· DDBJ | Genomic DNA | ||
AF387674 EMBL· GenBank· DDBJ | AAK70471.1 EMBL· GenBank· DDBJ | Genomic DNA | ||
AK017578 EMBL· GenBank· DDBJ | BAB30815.1 EMBL· GenBank· DDBJ | mRNA | ||
AJ006802 EMBL· GenBank· DDBJ | CAA07257.1 EMBL· GenBank· DDBJ | mRNA |